As ‘Michael 2' Comes Together, Lionsgate Film Chief Confident Studio Can Pull Off Another “Big And Satisfying Movie For A Global Audience”

Lionsgate said it is making strong progress on a second Michael Jackson film, with 25% to 30% of the movie already shot from prior production activity. Management said discussions with relevant parties are going well and expressed confidence the sequel can appeal to a global audience, while CEO Jon Feltheimer said the first film is on track to be the company’s first to exceed $1 billion globally. The update is constructive for Lionsgate’s film slate but does not include a formal financial revision.

Analysis

The important read-through is not just that the franchise appears to be scaling, but that Lionsgate is effectively turning a high-beta IP success into a lower-risk sequelization asset. If a meaningful chunk of the next installment is already financed via prior production, the sequel’s incremental capital intensity should be materially lower than a cold-start greenlight, which improves expected ROIC and de-risks the studio slate. That matters because in media the market usually underappreciates how one breakout title can compress the perceived cost of capital for adjacent projects and strengthen negotiating leverage with talent, distributors, and exhibitors.

The second-order winner is the equity story around IP libraries: a successful follow-on creates an annuity-like signaling effect that can lift valuation multiples beyond just the movie’s direct cash flow. If the first film clears the box office threshold implied here, the market may begin to ascribe option value to other under-monetized catalogs and sequels, which is typically more durable than one-quarter earnings noise. Competitively, this also pressures smaller studios to chase fewer, larger tentpoles, raising development risk and widening the gap between owners of proven franchises and “content volume” players.

The main risk is timing and sentiment asymmetry: in the near term, the stock can re-rate on sequel commentary, but the upside can unwind quickly if release cadence slips, economics are less clean than assumed, or audience fatigue emerges on a multi-part treatment. There is also event risk around legacy-artist narratives; any negative public controversy can hit both theatrical demand and music-catalog monetization expectations, especially if investors start extrapolating beyond the film into broader licensing. Over the next 3–6 months, the key catalyst is whether management converts optimism into a concrete production and release timetable; absent that, the move can fade into a valuation trap.

Key Decisions for Investors

• Long LION into any pullback over the next 2-4 weeks; use the sequel optionality as a catalyst trade, targeting a 10-15% re-rating if management provides a firmer production/release roadmap. Trim if the stock spikes >8% on headline enthusiasm without schedule confirmation.
• Buy 3-6 month call spreads on LION rather than outright stock to capture upside from sequel confirmation while capping downside if the project stalls; favor strikes ~15-20% above spot for better risk/reward.
• Pair trade: long LION / short a higher-multiple media peer with weaker franchise visibility over the next quarter; the thesis is that investors will pay up for repeatable IP monetization rather than undifferentiated content volume.
• If LION rallies hard on sequel headlines, look to fade into strength on the basis that the market may be pricing in revenue before production and distribution risk is fully removed; use a trailing stop around the pre-announcement breakout level.